… breast cancer who are getting adjuvant endocrine therapies with tamoxifen or aromatase inhibitors … offer symptom relief to breast cancer patients getting adjuvant endocrine … nurse after a breast cancer diagnosis had the same breast-cancer related outcomes …

… )–positive, HER2-negative breast cancer, according to data … metastatic breast cancer in combination with an aromatase inhibitor as … therapy administered for breast cancer.1 Patients were … , hormone receptor-positive breast cancer. Endocr Relat Cancer. …

… males. Improvements in breast cancer screening have helped identify breast cancer sooner, allowing for … selective estrogen receptor modulators or aromatase inhibitors. Surgery may include completely removing …

… breast cancer. 1. Breast cancer encompasses multiple histologic and molecular subtypes. Breast cancer … new invasive breast cancers. Inflammatory breast cancer is a … group of breast tumors marked by … therapies include aromatase inhibitors and selective estrogen …

… prostate cancer and adjuvant aromatase inhibitor therapy for breast cancer. It is also approved …

… fracture receiving adjuvant aromatase inhibitor therapy for breast cancer, according to a … women receiving adjuvant aromatase inhibitor therapy for breast cancer. These treatments are … patients with prostate or breast cancer, maintaining bone health during …

… in women with nonmetastatic breast cancer receiving adjuvant aromatase inhibitor (AI) therapy, and to … patients with bone metastases from breast cancer, prostate cancer, non-small cell …

… , and women receiving adjuvant aromatase inhibitor therapy for breast cancer at high risk for …

… for fracture receiving adjuvant aromatase inhibitor therapy for breast cancer. AUKELSO is approved for …

… for fracture receiving adjuvant aromatase inhibitor therapy for breast cancer. Aukelso is approved for …